Search - tctmd.com

Displaying 1 - 20 of 257

Sort: Relevancy | Date

News Daily News

Better LDL Control After STEMI Means Less Neoatherosclerosis

Yael L. Maxwell

December 23, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Yael L. Maxwell

March 24, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

Advertisement

Better LDL Control After STEMI Means Less Neoatherosclerosis

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

DES Best for In-Stent Restenosis, but DCBs Also Viable

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Coronary Artery Disease News of 2023

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

No Stents in STEMI? With Careful Selection, Maybe

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content